Compare Banco Bilbao Vizcaya Argentaria SA (BBVA) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Banco Bilbao Vizcaya Argentaria SA vs Sanofi SA — how do they compare? Banco Bilbao Vizcaya Argentaria SA trades at $28.6 (market cap $157.51B), while Sanofi SA trades at $43.25 (market cap $104.57B). The key difference: Banco Bilbao Vizcaya Argentaria SA is the larger of the two by market cap, and Sanofi SA pays the higher dividend (5.56%). Which is the better fit depends on your goals.
| BBVA | SNY | |
|---|---|---|
Market Cap | $157.51B | $104.57B |
Sector | Financials | Health |
52-Week High | $28.50 | $52.34 |
52-Week Low | $17.96 | $41.33 |
Dividend Yield | 3.8% | 5.56% |
Enterprise Value | — | $124.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Banco Bilbao Vizcaya Argentaria SA
Despite its Spanish origins, BBVA generates three quarters of its profits in emerging markets, especially Mexico that contributes nearly half of BBVA's net profit. BBVA is overwhelmingly a retail and commercial bank with corporate and investment banking forming a smaller part of the overall business.
Read more on BBVA →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
